The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Concerns over new age weight loss, diabetes drugs ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades. The FDA says the okay ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting “good momentum” for its already-approved Victoza, and its successor semaglutide.

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of ...

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...